| 26/403 |
High-Cost Drugs in Ophthalmology |
| 26/401 |
Pagers and Fax Machines |
| 26/400 |
Oncology Renal Cell Carcinoma |
| 26/399 |
Patient Level Information and Costing Systems (PLICS) |
| 26/398 |
Insourcing Expenditure 2025/26 |
| 26/397 |
Halogen Lighting |
| 26/394 |
Use of Corporate Credit Cards or Purchasing Cards by Employees of the Trust |
| 26/392 |
Lung Cancer |
| 26/389 |
Adoption of IHRA definition and Contact Details |
| 26/388 |
Oncology Breast Cancer |
| 26/387 |
Emergency Department Evacuation Exercise |
| 26/386 |
Agency Spend |
| 26/385 |
Nasogastric Tubes |
| 26/384 |
Enhanced Therapeutic Observation and Care (ETOC) Policy |
| 26/383 |
Maternity |
| 26/382 |
Management of Monogenic Diabetes in Pregnancy |
| 26/380 |
Staff Log-ins from Overseas during 2025-26 |
| 26/378 |
Biologics Medicines in Gastroenterology |
| 26/377 |
Memory Assessment Service Staffing (WTE) |
| 26/375 |
Paracetamol Overdose Presentations 2024/25 |
